The guideline recommends testing tissue transglutaminase IgA (tTGA) and total serum IgA for suspected celiac disease and testing hemoglobin, leukocytes and ESR for suspected inflammatory bowel disease (IBD). The gene discussed is CD79A; the disease is inflammatory bowel disease.